Supreme Court Upholds Conviction as Husband Failed to Explain Wife’s Death in Matrimonial Home  ||  Supreme Court: Crime Scene Re-Enactment Does Not Always Violate Right Against Self-Incrimination  ||  Supreme Court: Cognizance Taken Without Hearing Accused under BNSS Section 223 is Void Ab Initio  ||  Supreme Court Upholds Will in Sister’s Favour, Says Excluding Natural Heirs is Not Suspicious  ||  Delhi HC: Absence of Public Witnesses and Videography in NDPS Recovery Relevant for Bail Decisions  ||  Raj HC Initiates Suo Motu Cognizance Over Severe Water Crisis in Jodhpur, Issues Interim Directions  ||  Del HC: Courts Cannot Direct, Monitor Inquiry Into Police Delay in Investigation After Bail Decision  ||  Supreme Court: After the BNSS, a Pre-Cognizance Hearing is Mandatory in PMLA Cases  ||  SC: Landowners Cannot be Forced to Waive Statutory Compensation to Claim Other Benefits  ||  Supreme Court: Banks are Lenient With Big Borrowers But Strict With Ordinary Loan Applicants    

National Pharmaceutical Pricing Authority Notifies All Medical Devices Under Price Control - (02 Apr 2020)

LAW OF MEDICINE

National Pharmaceutical Pricing Authority has notified all medical devices sold in India as ‘drugs’ to bring the devices — such as syringes, needles, cardiac stents, a knee implant, digital thermometers, CT scan, MRIs and dialysis machines — under the purview of price control and prohibit firms from hiking their costs by more than 10% annually at a time.

Tags : NATIONAL PHARMACEUTICAL PRICING AUTHORITY   ALL MEDICAL DEVICES UNDER PRICE CONTROL  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved